The impact of lubiprostone on mucus secretion in asymptomatic volunteers and patients with chronic constipation

Trial Profile

The impact of lubiprostone on mucus secretion in asymptomatic volunteers and patients with chronic constipation

Completed
Phase of Trial: Phase II/III

Latest Information Update: 16 Jun 2017

At a glance

  • Drugs Lubiprostone (Primary)
  • Indications Constipation
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 01 Oct 2013 NCT00595036 is an obsolete identifier according to ClinicalTrials.gov record NCT01447849.
    • 01 Oct 2013 NCT00595036 is an obsolete identifier according to ClinicalTrials.gov record NCT01447849.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top